FINWIRES · TerminalLIVE
FINWIRES

$DAVA

42 stories mentioning DAVAUpdated 2d ago

Every FINWIRES story that references DAVA, newest first.

What are analysts saying about DAVA?

Recent broker actions mentioned in FINWIRES coverage. Compiled from wire headlines; not investment advice.

What's the latest news on DAVA?

Asia Markets

European Equities Traded in the US as American Depositary Receipts Sharply Lower in Tuesday Trading

European equities traded in the US as American depositary receipts were falling sharply late Tuesday morning, dropping 1.15% to 1,812.72 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by petroleum refiner Equinor (EQNR) and internet browser company Opera (OPRA), which rose 2.7% and 1.7% respectively. They were followed by 3D printer company Materialise (MTLS) and medical device maker EDAP TMS (EDAP), which were up 1.2% each.The decliners from continental Europe were led by biopharmaceutical company argenx (ARGX) and pharmaceutical company Novo Nordisk (NVO), which fell 3% and 2.8% respectively. They were followed by biotech firm Evaxion (EVAX) and pharmaceutical company Ascendis Pharma (ASND), which were down 2.7% each.The gainers from the UK were led by biopharmaceutical company Akari Therapeutics (AKTX) and software firm Endava (DAVA), which advanced 6.4% and 2.7% respectively. They were followed by education company Pearson (PSO) and pharmaceutical company Silence Therapeutics (SLN), which increased 1.2% and 0.9% respectively.The decliners from the UK and Ireland were led by biopharmaceutical companies Biodexa Pharmaceuticals (BDRX) and NuCana (NCNA), which dropped 8.7% and 3.2% respectively. They were followed by biopharmaceutical company Mereo BioPharma Group (MREO) and cruise line operator Carnival (CUK), which lost 2.3% and 2.2% respectively.

$AKTX$ARGX$ASND$BDRX$CUK$DAVA$EDAP$EQNR$EVAX$MREO$MTLS$NCNA$NVO$OPRA$PSO$SLN
Asia Markets

European Equities Traded in the US as American Depositary Receipts Rise in Friday Trading

European equities traded in the US as American depositary receipts were tracking higher late Friday morning, gaining 0.75% to 1,828.19 on the S&P Europe Select ADR Index, which is up 4% for the week.From continental Europe, the gainers were led by biopharmaceutical company Cellectis (CLLS) and lender Banco Bilbao Vizcaya Argentaria (BBVA), which climbed 6.6% and 2% respectively. They were followed by health-tech conglomerate Royal Philips (PHG) and biopharmaceutical company Grifols (GRFS), which rose 1.6% and 1.4% respectively.The decliners from continental Europe were led by biopharmaceutical company DBV Technologies (DBVT) and internet browser company Opera (OPRA), which fell 2.7% and 2.5% respectively. They were followed by internet advertising firm Criteo (CRTO) and pharmaceutical company Ascendis Pharma (ASND), which dropped 1.8% and 1.4% respectively.The gainers from the UK were led by biotech firm Autolus Therapeutics (AUTL) and biopharmaceutical company Biodexa Pharmaceuticals (BDRX), which advanced 5.1% and 4.3% respectively. They were followed by biotech company Trinity Biotech (TRIB) and medical device maker Smith & Nephew (SNN), which were up 2.3% and 2.1% respectively.The decliners from the UK and Ireland were led by pharmaceutical company Silence Therapeutics (SLN) and software firm Endava (DAVA), which lost 4.6% and 2.1% respectively. They were followed by biopharmaceutical companies Akari Therapeutics (AKTX) and Amarin (AMRN), which were down 1.9% and 1.5% respectively.

$AKTX$AMRN$ASND$AUTL$BBVA$BDRX$CLLS$CRTO$DAVA$DBVT$GRFS$OPRA$PHG$SLN$SNN$TRIB

Showing 41-42 of 42

Track with the FINWIRES app suite